Context.—The macrofollicular variant of papillary carcinoma of the thyroid is a rare entity described by J. Albores-Saavedra and colleagues in 1991. It is characterized histologically by a predominance of macrofollicles and clinically by a low incidence of metastasis. This entity may represent a source of diagnostic error, since it can be easily misinterpreted as a macrofollicular adenoma or nodular goiter.

Design.—In this study, we describe 3 cases of papillary carcinoma of the thyroid with a macrofollicular growth pattern and review the literature.

Results.—The fine-needle aspiration biopsies in 2 cases showed large cells with optically clear nuclei and nuclear grooves, suggestive of papillary carcinoma of the thyroid. In one case, the cytology showed no signs of malignancy. In all cases, the tumors showed a combination of the conventional follicular variant of papillary carcinoma of the thyroid and macrofollicles (diameter, >250 μm) occupying more than 50% of the cross-sectional area. Cytologic features were large, cuboidal cells with optically clear, ground-glass nuclei with smooth outlines, a fine chromatin pattern, nuclear grooves, and pseudoinclusions. The colloid was dense and more eosinophilic than in adjacent normal follicles. In 2 cases, there was capsular or blood vessel infiltration, and one tumor had metastasized to a cervical lymph node. One tumor recurred 1 year later as an anaplastic carcinoma. Immunohistochemical staining showed a positivity of the tumor cells for cytokeratins 7, 17, and 19, thyroid transcription factor-1, and galectin-3 and a negativity for cytokeratin 20 and p53.

Conclusions.—Although it has been suggested that this tumor is a highly differentiated variant with a favorable prognosis, our study shows that its biologic behavior is not conclusive because metastases and recurrences with dedifferentiation may occur.

Papillary carcinoma, the most common malignant tumor of the thyroid gland, has a very broad morphologic spectrum.1 In 1991, Albores-Saavedra et al2 described 17 cases of a macrofollicular variant of an encapsulated papillary carcinoma of the thyroid, which can be easily confused with nodular goiter or benign follicular adenoma. According to the definition given by these authors, the macrofollicular variant of papillary carcinoma of the thyroid is characterized histologically by a predominance of macrofollicles (>50% of a cross-sectional area) and clinically by nonaggressive biologic behavior. In recent years, only a few additional cases of this entity have been described, mainly as single case reports.3–5 

Considering the histologic, cytologic, and immunohistochemical features of the macrofollicular variant of papillary carcinoma, there is a broad spectrum of differential diagnoses as follicular adenoma, nodular goiter, or Hashimoto thyroiditis. Cytologic features appear to be discriminatory for the differential diagnosis.

In this study, we describe the clinical and pathologic features of 3 cases of this rare entity, one of them recurring 1 year later as an anaplastic carcinoma, and review the literature.

The cases were retrieved from the surgical pathology files of the University Hospital, Basel, Switzerland. The Papanicolaou-stained cytologic specimens from the presurgical fine-needle aspiration biopsies and the hematoxylin-eosin–stained and elastica-Van Gieson–stained sections of the resected tumors were reviewed. Paraffin blocks were available in all 3 cases, and additional 5-μm-thick sections were prepared for immunohistochemical studies. Immunostaining was performed using the ABC-Elite-Method (Vector, Burlingame, Calif) for thyroid transcription factor-1, p53, cytokeratins 7, 17, 19, and 20, and galectin-3. For each antigen tested, positive and negative control sections were stained simultaneously. The antibodies used, their sources, and their dilutions are provided in Table 1.

Table 1.

Primary Antibodies and Pretreatment Protocols*

Primary Antibodies and Pretreatment Protocols*
Primary Antibodies and Pretreatment Protocols*

Case 1

A 38-year-old woman presented at physical examination with a nodular, solitary mass in the inferior part of the left thyroid lobe. Ultrasonography detected a solid-cystic nodule, and a fine-needle aspiration biopsy showed atypical epithelial cells with ground-glass, overlapping nuclei, nuclear grooves, and prominent nucleoli (Figure 1). These morphologic features were consistent with a papillary carcinoma of the thyroid. A total thyroidectomy was performed. Macroscopically, the solitary, partially encapsulated nodule in the left thyroid lobe measured 1.4 cm in diameter and was surrounded by normal thyroid tissue. Histologically, it was characterized by a macrofollicular growth pattern (Figure 2), lined by large, cuboidal cells with optically clear, ground-glass, focally overlapping nuclei with nuclear grooves, pseudoinclusions, and prominent nucleoli (Figure 3). The macrofollicles contained dense and eosinophilic colloid. A focal capsule infiltration was detected. The right thyroid lobe showed no evidence of a tumor.

Figure 1.

Fine-needle aspiration biopsy showing atypical epithelial cells with optically clear, ground-glass, overlapping nuclei with nuclear grooves and prominent nucleoli (original magnification ×100). Figure 2. Total thyroidectomy reveals papillary carcinoma with a macrofollicular growth pattern (hematoxylin-eosin, original magnification ×5). Figure 3. Macrofollicles lined by large cuboidal cells with clear ground-glass nuclei (hematoxylin-eosin, original magnification ×100). Figure 4. Undifferentiated anaplastic carcinoma with capsule and blood vessel infiltration (hematoxylin-eosin, original magnification ×5). Figure 5. Undifferentiated anaplastic carcinoma with diffuse growth pattern (hematoxylin-eosin, original magnification ×20). Figure 6. Lymph node metastasis of a papillary thyroid carcinoma, macrofollicular variant (hematoxylin-eosin, original magnification ×10)

Figure 1.

Fine-needle aspiration biopsy showing atypical epithelial cells with optically clear, ground-glass, overlapping nuclei with nuclear grooves and prominent nucleoli (original magnification ×100). Figure 2. Total thyroidectomy reveals papillary carcinoma with a macrofollicular growth pattern (hematoxylin-eosin, original magnification ×5). Figure 3. Macrofollicles lined by large cuboidal cells with clear ground-glass nuclei (hematoxylin-eosin, original magnification ×100). Figure 4. Undifferentiated anaplastic carcinoma with capsule and blood vessel infiltration (hematoxylin-eosin, original magnification ×5). Figure 5. Undifferentiated anaplastic carcinoma with diffuse growth pattern (hematoxylin-eosin, original magnification ×20). Figure 6. Lymph node metastasis of a papillary thyroid carcinoma, macrofollicular variant (hematoxylin-eosin, original magnification ×10)

Close modal

Case 2

A 72-year-old woman with a multinodular enlargement of the thyroid gland underwent a subtotal bilateral thyroidectomy because of a progressive tracheal compression. A fine-needle aspiration biopsy showed no cytologic features characteristic of papillary carcinoma of the thyroid. Grossly, the thyroid showed several nodules, partially encapsulated, measuring 2 to 10 mm. One nodule (diameter, 1 cm) displayed a diffuse macrofollicular growth pattern. The follicles (diameter, >200 μm) were lined by large, cuboidal cells with optically clear nuclei and nuclear grooves. Diffuse infiltration of the thyroid capsule and infiltration of blood vessels were also detected (Figure 4). A diagnosis of macrofollicular papillary carcinoma of the thyroid was rendered.

The adjacent normal thyroid tissue presented features of a nodular goiter. Five days after this intervention, a complete thyroidectomy was performed.

One year later, at the prior tumor site, the patient developed an undifferentiated, anaplastic carcinoma with capsule, blood vessel, and lymph node infiltration (Figure 5).

Case 3

A 43-year-old man with a clinical history of goiter presented with a solitary nodule in the right thyroid lobe and an enlarged cervical lymph node on the right neck. Computed tomographic scanning showed no signs of metastases. The cells in a fine-needle aspiration biopsy showed single ground-glass nuclei with nuclear grooves, but these were less prominent than in case 1. A right thyroid lobectomy, a subtotal left thyroid lobectomy, and a neck dissection were performed.

Grossly, the nodule (diameter, 6 cm) consisted of several cysts measuring 7 mm. Histologically, the nodule was completely encapsulated and presented as a macrofollicular growth pattern with cytologic features similar to those of cases 1 and 2. Follicles were lined by large, cuboidal cells with clear nuclei, nuclear grooves, and a fine chromatin pattern. The colloid of these follicles was denser and more eosinophilic than that of the adjacent normal follicles. Capsule or blood vessel infiltration by the tumor could not be detected. The enlarged cervical lymph node showed a metastasis of the macrofollicular variant of papillary carcinoma of the thyroid (Figure 6).

The clinical and pathologic features of the 3 cases are summarized in Table 2.

Table 2.

Clinicopathologic Features of the Macrofollicular Variant of Papillary Thyroid Cancer*

Clinicopathologic Features of the Macrofollicular Variant of Papillary Thyroid Cancer*
Clinicopathologic Features of the Macrofollicular Variant of Papillary Thyroid Cancer*

Immunohistochemical Findings

In all 3 cases, a positivity for cytokeratins 7, 17, and 19, thyroid transcription factor-1, and galectin-3 and a negativity for cytokeratin 20 and p53 were observed. The immunohistochemical results are shown in Table 3.

Table 3.

Immunohistochemical Reactivity of Cytokeratin, TTF-1, and p53 in the Macrofollicular Variant of Papillary Carcinoma of the Thyroid*

Immunohistochemical Reactivity of Cytokeratin, TTF-1, and p53 in the Macrofollicular Variant of Papillary Carcinoma of the Thyroid*
Immunohistochemical Reactivity of Cytokeratin, TTF-1, and p53 in the Macrofollicular Variant of Papillary Carcinoma of the Thyroid*

The macrofollicular variant of papillary carcinoma of the thyroid is a rare entity, first described by Albores-Saavedra et al2 in 1991. According to its definition, more than 50% of the cross-sectional area of the tumor must be composed of macrofollicles (follicles, >250 μm), lined by cells with features characteristic of papillary carcinoma, namely nuclear grooves and optically clear or ground-glass nuclei. Until now, approximately 38 cases of the macrofollicular variant have been reported in the literature.2–7 The main reported features are summarized in Table 4.

Table 4.

Macrofollicular Variant of Papillary Thyroid Cancer: A Review of the Literature*

Macrofollicular Variant of Papillary Thyroid Cancer: A Review of the Literature*
Macrofollicular Variant of Papillary Thyroid Cancer: A Review of the Literature*

Women seem to be more affected than men,2 although recently, several reported cases have concerned men.4,7 In our study, 2 females and 1 male were included.

We detected a regional lymph node metastasis in 1 of 3 cases, whereas Albores-Saavedra et al2 detected a lymph node metastasis in 2 of 17 (11.8%) cases. Evans8 observed metastasis to a regional lymph node in 1 of 14 patients (7.1%). In contrast to the conventional papillary carcinoma, with a reported prevalence of regional lymph node metastases between 35%9 and 50%,10 the low incidence of lymph node metastasis in the macrofollicular variant of papillary carcinoma of the thyroid is probably due to the presence of a well-defined capsule.2 

The mean diameter of the 3 papillary carcinomas in our study was 2.8 cm. In the reported series, the range was 2.3 to 8 cm (Table 1). Considering the 17 cases of Albores-Saavedra et al,2 the macrofollicular variant of papillary thyroid cancer pursues a less aggressive clinical course than the conventional form. The tumor with the smallest diameter (1 cm) recurred as an undifferentiated, anaplastic carcinoma with sarcomatoid differentiation and lymph node infiltration, whereas the other 2 tumors (diameters, 1.4 and 6.0 cm, respectively) showed no signs of recurrence. Carcangiu et al1 and other authors11,12 have reported that many cases of undifferentiated thyroid carcinoma may not arise de novo, but rather as a result of the dedifferentiation of a papillary or follicular carcinoma. Our case could be an example of such a dedifferentiation.

Because of the macrofollicular pattern of this variant of papillary carcinoma of the thyroid, the differential diagnosis with benign diseases such as goiter, macrofollicular adenoma, Graves disease, or hyperplastic nodule may be challenging.

In follicular adenomas, the macrofollicles are lined by flat epithelial cells showing hyperchromatic nuclei, and in Graves disease, colloid and macrofollicles are not abundant.2 

The clear nucleus-Orphan Annie eye13,14 is accepted as one of the important features of papillary carcinoma. Hapke and Dehner13 studied 100 cases of thyroid lesions exclusive of papillary, follicular, or mixed carcinoma. Only 2% (diffuse hyperplasia and follicular adenoma) showed such nuclear morphology; meanwhile, 83% of the papillary carcinomas showed clear or empty nuclei. Other authors1,15,16 have examined the “conventional” follicular variant of papillary carcinoma, and the ground-glass nucleus was one of the diagnostic clues for papillary carcinoma. Pseudoinclusions or nuclear grooving is also supposed to be characteristic of papillary carcinoma.17 However, Scopa et al18 examined 80 nonpapillary thyroid lesions and found nuclear grooves in all but 11 cases (adenomatous hyperplasia and nodular goiter). Since a focal presence of grooves can occur in nonneoplastic thyroid lesions, the quantity of grooved cells (focal or diffuse) and the nuclear shape need to be considered.17–19 In summary, prominent, diffuse, clear, overlapping, “irregular” nuclei with nuclear grooves and pseudoinclusions are elements that strongly favor the diagnosis of papillary carcinoma.

The differential diagnosis of this tumor is even more crucial in frozen sections. Woyke et al5 reported a case in which the diagnosis in frozen section was benign, but a fine-needle aspiration biopsy showed features typical of papillary carcinoma. The cells had large nuclei with powdery chromatin and pseudoinclusions. The cytologic alterations are in fact difficult to appreciate in frozen sections. Cytologic examinations that take place while frozen sections are being prepared are hence a helpful technique to avoid this pitfall. Mesonero et al4 studied fine-needle aspiration biopsies of 16 cases of the macrofollicular variant of papillary carcinoma of the thyroid and suggested ovoid and pear-shaped nuclei, nuclear hypochromasia, and nuclear grooves as cytologic criteria. Less consistently, they found excentric, small nucleoli and nuclear overlap. Hirokawa et al3 considered the presence of large colloid next to ground-glass nuclei important for differentiating between the macrofollicular and conventional variant of papillary carcinoma.

In the literature, the immunohistochemical profile of papillary carcinoma of the thyroid is not absolutely discriminatory. Papillary carcinomas express keratin and thyroglobulin.20 The presence of cytokeratin 19 in papillary carcinoma of the thyroid seems to be useful in the differential diagnosis from normal thyroid gland tissue as well as from benign and malignant follicular neoplasms.21 Thyroid transcription factor-1 is expressed in more than 95% of follicular and papillary thyroid carcinomas as well as in normal thyroid glands.22 In the macrofollicular variant of papillary carcinoma of the thyroid, a positivity was found for cytokeratin and thyroglobulin.2 Galectin-3 is expressed in greater amounts in papillary thyroid cancers but rarely in normal thyroids.23–28 In our study, all 3 cases were positive for cytokeratins 7, 17, and 19, thyroid transcription factor-1, and galectin-3. Like the case reported by Nakamura et al,7 our cases did not show a positivity for p53.

In summary, we report 3 additional cases of the macrofollicular variant of papillary carcinoma of the thyroid. Although this entity has a favorable prognosis, recurrences and metastases may occur. The role of cytologic evaluation in the differential diagnosis is prominent.

Carcangiu
,
M. L.
,
G.
Zampi
,
A.
Pupi
,
A.
Castagnoli
, and
J.
Rosai
.
Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy.
Cancer
1985
.
55
:
805
828
.
Albores-Saavedra
,
J.
,
E.
Gould
,
C.
Vardaman
, and
F.
Vuitch
.
The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases.
Hum Pathol
1991
.
22
:
1195
1205
.
Hirokawa
,
M.
,
M.
Shimizu
,
K.
Terayama
,
T.
Kanahara
,
H.
Sonoo
, and
T.
Manabe
.
Macrofollicular variant of papillary thyroid carcinoma: report of a case with fine needle aspiration biopsy findings.
Acta Cytol
1998
.
42
:
1441
1443
.
Mesonero
,
C. E.
,
J. E.
Jugle
,
D. C.
Wilbur
, and
R.
Nayar
.
Fine-needle aspiration of the macrofollicular and microfollicular subtypes of the follicular variant of papillary carcinoma of the thyroid.
Cancer
1998
.
84
:
235
244
.
Woyke
,
S.
,
A. K.
al-Jassar
, and
H.
al-Jazzaf
.
Macrofollicular variant of papillary thyroid carcinoma diagnosed by fine needle aspiration biopsy: a case report.
Acta Cytol
1998
.
42
:
1184
1188
.
Albores-Saavedra
,
J.
,
I.
Housini
,
F.
Vuitch
, and
W. H. I. I. I.
Snyder
.
Macrofollicular variant of papillary thyroid carcinoma with minor insular component.
Cancer
1997
.
80
:
1110
1116
.
Nakamura
,
T.
,
S.
Moriyama
,
S.
Nariya
,
K.
Sano
,
H.
Shirota
, and
R.
Kato
.
Macrofollicular variant of papillary thyroid carcinoma.
Pathol Int
1998
.
48
:
467
470
.
Evans
,
H. L.
Encapsulated papillary neoplasms of the thyroid: a study of 14 cases followed for a minimum of 10 years.
Am J Surg Pathol
1987
.
11
:
592
597
.
Carcangiu
,
M. L.
,
G.
Zampi
, and
J.
Rosai
.
Papillary thyroid carcinoma: a study of its many morphologic expressions and clinical correlates.
Pathol Annu
1985
.
20
:
1
44
.
Frazell
,
E. L.
and
F. W.
Foote
.
Papillary thyroid carcinoma.
Cancer
1955
.
8
:
1165
1166
.
Harada
,
T.
,
K.
Ito
,
K.
Shimaoka
,
Y.
Hosoda
, and
K.
Yakumaru
.
Fatal thyroid carcinoma: anaplastic transformation of adenocarcinoma.
Cancer
1977
.
39
:
2588
2596
.
Ibanez
,
M. L.
,
W. O.
Russell
,
J.
Albores-Saavedra
,
P.
Lampertico
,
E. C.
White
, and
R. L.
Clark
.
Thyroid carcinoma—biologic behavior and mortality: postmortem findings in 42 cases, including 27 in which the disease was fatal.
Cancer
1966
.
19
:
1039
1052
.
Hapke
,
M. R.
and
L. P.
Dehner
.
The optically clear nucleus: a reliable sign of papillary carcinoma of the thyroid?
Am J Surg Pathol
1979
.
3
:
31
38
.
DeLellis
,
R. A.
Orphan Annie eye nuclei: a historical note.
Am J Surg Pathol
1993
.
17
:
1067
1068
.
Sobrinho-Simoes
,
M.
,
J.
Soares
, and
F.
Carneiro
.
et al
.
Diffuse follicular variant of papillary carcinoma of the thyroid.
Surg Pathol
1990
.
3
:
189
203
.
Chem
,
K. T.
and
J.
Rosai
.
Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases.
Am J Surg Pathol
1977
.
1
:
123
130
.
Chan
,
J. K.
and
D.
Saw
.
The grooved nucleus: a useful diagnostic criterion of papillary carcinoma of the thyroid.
Am J Surg Pathol
1986
.
10
:
672
679
.
Scopa
,
C. D.
,
M.
Melachrinou
,
C.
Saradopoulou
, and
M. J.
Merino
.
The significance of the grooved nucleus in thyroid lesions.
Mod Pathol
1993
.
6
:
691
694
.
LiVolsi
,
V. A.
Papillary neoplasms of the thyroid. Pathologic and prognostic features.
Am J Clin Pathol
1992
.
97
:
426
434
.
Permanetter
,
W.
,
W. B.
Nathrath
, and
U.
Löhrs
.
Immunohistochemical analysis of thyroglobulin and keratin in benign and malignant thyroid tumours.
Virchows Arch
1982
.
398
:
221
228
.
Schelfhout
,
L. J.
,
G. N.
Van Muijen
, and
G. J.
Fleuren
.
Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma.
Am J Clin Pathol
1989
.
92
:
654
658
.
Katoh
,
R.
,
A.
Kawaoi
, and
E.
Miyagi
.
et al
.
Thyroid transcription factor-1 in normal, hyperplastic and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
Mod Pathol
2000
.
13
:
570
576
.
Kawachi
,
K.
,
Y.
Matsushita
, and
S.
Yonezawa
.
et al
.
Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation.
Hum Pathol
2000
.
31
:
428
433
.
Herrmann
,
M. E.
,
V. A.
LiVolsi
,
T. L.
Pasha
,
S. A.
Roberts
,
E. M.
Wojcik
, and
Z. W.
Baloch
.
Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions.
Arch Pathol Lab Med
2002
.
126
:
710
713
.
Coli
,
A.
,
G.
Bigotti
,
F.
Zucchetti
,
F.
Negro
, and
G.
Massi
.
Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia.
Histopathology
2002
.
40
:
80
87
.
Niedobitek
,
C.
,
F.
Niedobitek
, and
G.
Lindenberg
.
et al
.
Untersuchungen zur Expression von Galectin-3 im Schilddrüsengewebe und in Follikelzelltumoren der Schilddrüse.
Pathologe
2001
.
22
:
205
213
.
Bartolazzi
,
A.
,
A.
Gasbarri
, and
M.
Papotti
.
et al, and the Thyroid Cancer Study Group
.
Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions.
Lancet
2001
.
357
:
1644
1650
.
Beesley
,
M. F.
and
K. M.
McLaren
.
Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules.
Histopathology
2002
.
41
:
236
243
.

Author notes

Reprints: Luigi Tornillo, MD, Institut für Pathologie, der Universität, Schöneinstrasse 40, CH-4003 Basel, Switzerland ([email protected])